Man Group PLC Neuro Pace Inc Transaction History

Man Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.38 - $15.33 $3,368 - $8,094	528 Added 1.39%	38,470 $290,000
Q1 2024 May 15, 2024	BUY	$9.78 - $17.5 $182,338 - $326,270	18,644 Added 96.61%	37,942 $500,000
Q4 2023 Feb 14, 2024	BUY	$5.9 - $10.31 $113,858 - $198,962	19,298 New	19,298 $198,000

21.3M

1.3K

100

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $241M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.